AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
DLGAP2 | Discs, large (Drosophila) homolog-associated protein 2 | Nuclear receptors Predicted intracellular proteins
| | | | | Group enriched |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
ESR2 | Estrogen receptor 2 (ER beta) | Cancer-related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ESRRA | Estrogen-related receptor alpha | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
ESRRG | Estrogen-related receptor gamma | FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
HNF4G | Hepatocyte nuclear factor 4, gamma | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
NR0B1 | Nuclear receptor subfamily 0, group B, member 1 | Cancer-related genes Disease related genes Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
NR1D1 | Nuclear receptor subfamily 1, group D, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR1D2 | Nuclear receptor subfamily 1, group D, member 2 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR1H2 | Nuclear receptor subfamily 1, group H, member 2 | Cancer-related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR1H3 | Nuclear receptor subfamily 1, group H, member 3 | Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR1H4 | Nuclear receptor subfamily 1, group H, member 4 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR1I3 | Nuclear receptor subfamily 1, group I, member 3 | Cytoskeleton related proteins Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
NR2C1 | Nuclear receptor subfamily 2, group C, member 1 | Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR2C2 | Nuclear receptor subfamily 2, group C, member 2 | Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR2E1 | Nuclear receptor subfamily 2, group E, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
NR2F1 | Nuclear receptor subfamily 2, group F, member 1 | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Mixed |
NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR3C2 | Nuclear receptor subfamily 3, group C, member 2 | Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR4A1 | Nuclear receptor subfamily 4, group A, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR4A2 | Nuclear receptor subfamily 4, group A, member 2 | Cancer-related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR4A3 | Nuclear receptor subfamily 4, group A, member 3 | Cancer-related genes Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR5A2 | Nuclear receptor subfamily 5, group A, member 2 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Mixed |
NR6A1 | Nuclear receptor subfamily 6, group A, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
PGR | Progesterone receptor | Cancer-related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
PPARD | Peroxisome proliferator-activated receptor delta | FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PPARG | Peroxisome proliferator-activated receptor gamma | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
RARA | Retinoic acid receptor, alpha | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
RARB | Retinoic acid receptor, beta | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Mixed |
RARG | Retinoic acid receptor, gamma | Cancer-related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
RORA | RAR-related orphan receptor A | Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
RORB | RAR-related orphan receptor B | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
RORC | RAR-related orphan receptor C | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Mixed |
RXRA | Retinoid X receptor, alpha | Cancer-related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
RXRB | Retinoid X receptor, beta | Cancer-related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
RXRG | Retinoid X receptor, gamma | Cancer-related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
THRA | Thyroid hormone receptor, alpha | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
THRB | Thyroid hormone receptor, beta | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
VDR | Vitamin D (1,25- dihydroxyvitamin D3) receptor | Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |